United Therapeutics Corporation (UTHR) Ownership

$0.00

$0 (0%)
Last update: 07:00 PM EST
Day's range
$495.5
Day's range
$530.47

United Therapeutics Corp Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
BLACKROCK, INC. 02/12/2026 5.17 M $2.52 B   -3.40% 11.81%
VANGUARD GROUP INC 01/29/2026 4.18 M $2.03 B   -5.49% 9.53%
AVORO CAPITAL ADVISORS LLC 03/16/2026 2.61 M $1.27 B   28.87% 5.95%
WELLINGTON MANAGEMENT GROUP LLP 02/17/2026 2.44 M $1.19 B   74.54% 5.57%
RENAISSANCE TECHNOLOGIES LLC 02/12/2026 1.91 M $930.29 M   -12.15% 4.36%
STATE STREET CORP 02/13/2026 1.84 M $897.71 M   -4.17% 4.21%
AQR CAPITAL MANAGEMENT LLC 02/17/2026 1.28 M $624.51 M   29.93% 2.93%
GEODE CAPITAL MANAGEMENT, LLC 02/09/2026 1.19 M $580.24 M   -4.53% 2.72%
JANUS HENDERSON GROUP PLC 02/17/2026 796.10 K $387.80 M   75.08% 1.82%
ASSETMARK, INC 01/23/2026 634.96 K $309.38 M   -1.70% 1.45%
INVESCO LTD. 02/19/2026 608.76 K $296.62 M   -4.47% 1.39%
NORGES BANK 02/10/2026 602.19 K $293.42 M   100.00% 1.37%
DIMENSIONAL FUND ADVISORS LP 02/12/2026 528.21 K $257.41 M   3.00% 1.21%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 02/17/2026 425.99 K $207.57 M   0.00% 0.97%
NORTHERN TRUST CORP 02/17/2026 418.43 K $203.88 M   -6.40% 0.96%
LSV ASSET MANAGEMENT 02/06/2026 408.07 K $198.83 M   -40.58% 0.93%
FMR LLC 02/17/2026 403.83 K $196.77 M   61.32% 0.92%
MORGAN STANLEY 02/13/2026 389.28 K $189.68 M   -11.29% 0.89%
PRICE T ROWE ASSOCIATES INC /MD/ 02/17/2026 352.09 K $171.56 M   17.00% 0.80%
BANK OF NEW YORK MELLON CORP 02/10/2026 333.63 K $162.56 M   -5.07% 0.76%
SWEDBANK AB 02/09/2026 324.77 K $158.25 M   -1.32% 0.74%
BAILLIE GIFFORD & CO 01/23/2026 323.02 K $157.39 M   100.00% 0.74%
D. E. SHAW & CO., INC. 02/17/2026 306.97 K $149.57 M   374.37% 0.70%
PICTET ASSET MANAGEMENT HOLDING SA 01/29/2026 306.84 K $149.67 M   -4.56% 0.70%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 02/17/2026 305.10 K $148.66 M   -12.70% 0.70%
CAISSE DE DEPOT ET PLACEMENT DU QUEBEC 02/17/2026 296.32 K $144.38 M   201.95% 0.68%
FULLER & THALER ASSET MANAGEMENT, INC. 02/18/2026 290.61 K $141.60 M   -7.83% 0.66%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 02/13/2026 289.93 K $141.27 M   -7.36% 0.66%
JPMORGAN CHASE & CO 02/11/2026 262.22 K $127.76 M   5.76% 0.60%
LORD, ABBETT & CO. LLC 02/13/2026 258.05 K $125.73 M   -4.10% 0.59%
EVERSEPT PARTNERS, LP 02/17/2026 252.59 K $123.08 M   -0.25% 0.58%
NUVEEN, LLC 02/12/2026 251.81 K $122.69 M   -12.28% 0.57%
PACER ADVISORS, INC. 02/24/2026 241.87 K $117.85 M   -28.67% 0.55%
VICTORY CAPITAL MANAGEMENT INC 02/13/2026 228.38 K $111.28 M   108.08% 0.52%
UBS GROUP AG 01/29/2026 225.85 K $110.04 M   45.33% 0.52%
CAPTION MANAGEMENT, LLC 02/17/2026 222.80 K $108.56 M   -12.15% 0.51%
FIRST TRUST ADVISORS LP 02/13/2026 219.02 K $106.72 M   -27.11% 0.50%
JANE STREET GROUP, LLC 02/12/2026 216.82 K $105.65 M   359.60% 0.50%
ALLIANCEBERNSTEIN L.P. 02/17/2026 206.54 K $100.64 M   14.49% 0.47%
BANK OF AMERICA CORP /DE/ 02/17/2026 205.13 K $99.95 M   6.37% 0.47%
UBS ASSET MANAGEMENT AMERICAS INC 02/13/2026 203.35 K $99.08 M   0.08% 0.46%
ACADIAN ASSET MANAGEMENT LLC 02/10/2026 200.53 K $97.67 M   43.38% 0.46%
CITADEL ADVISORS LLC 02/17/2026 187.16 K $91.20 M   -31.69% 0.43%
POINT72 ASSET MANAGEMENT, L.P. 02/17/2026 186.16 K $90.71 M   86.57% 0.43%
CITIGROUP INC 02/13/2026 184.41 K $89.85 M   -66.56% 0.42%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 02/17/2026 182.50 K $88.92 M   -77.86% 0.42%
FRONTIER CAPITAL MANAGEMENT CO LLC 02/17/2026 181.18 K $88.28 M   4.16% 0.41%
FRANKLIN RESOURCES INC 02/11/2026 181.12 K $88.25 M   189.02% 0.41%
LEGAL & GENERAL GROUP PLC 02/09/2026 173.59 K $84.58 M   -13.05% 0.40%
AMUNDI 02/17/2026 163.19 K $79.52 M   25.55% 0.37%

United Therapeutics Corp institutional Ownership - FAQ's

During the previous two years, 1168 institutional investors and hedge funds held shares of United Therapeutics Corp. The most heavily invested institutionals were:

Bank of New York Mellon Corp: 329,148

Swedbank AB: 327,122

Pictet Asset Management Holding SA: 309,220

UBS Group AG: 236,729

Nuveen, LLC: 190,697

FIFTH THIRD BANCORP: 164,978

94.93% of United Therapeutics Corp stock is owned by institutional investors.

Institutional investors have bought a total of 58.15 M shares in the last 24 months. This purchase volume represents approximately $30.77 B in transactions.